Longevity Science · Visual Reference

Mechanisms of Action

Interactive pathway diagrams tracing the molecular cascades behind key longevity interventions — from receptor binding to cellular outcome.

Activator / Trigger
Inhibitor / Blocker
Pathway Node
Downstream Outcome
Six Core Pathways
The Molecular Landscape of Longevity
m
mTOR Pathway
Mechanistic Target of Rapamycin — master regulator of cell growth, protein synthesis, and autophagy. When inhibited, promotes longevity-associated cellular maintenance.
View Pathway
Growth Factors (IGF-1) PI3K AKT / PKB mTOR Complex 1 Protein Synthesis (S6K) Cell Growth Autophagy Inhibition ✗ Lipid Synthesis Rapamycin / Metformin Fasting / Caloric Restriction (via AMPK) Amino Acids / Insulin Chronic mTOR activation accelerates aging Inhibition shifts resources from growth to maintenance & repair
A
AMPK Pathway
AMP-activated Protein Kinase — the cellular energy sensor. Activated under metabolic stress, it triggers catabolic pathways that promote longevity and metabolic health.
View Pathway
Low Energy (AMP:ATP ↑) Exercise / Fasting Metformin / Berberine LKB1 Kinase AMPK AMP-Activated Protein Kinase Autophagy (ULK1 activation) Mitochondrial Biogenesis (PGC-1α) Glucose Uptake (GLUT4 translocation) Fatty Acid Oxidation (ACC inhib.) mTOR Inhibition ⊣ Cellular Cleanup Energy Production ↑ Insulin Sensitivity ↑ Fat Metabolism ↑ AMPK acts as a metabolic master switch Shifting the cell from anabolic (growth) to catabolic (repair & energy conservation) programs
S
Sirtuin / NAD+ Pathway
NAD+ fuels sirtuin deacetylases (SIRT1–7), key regulators of DNA repair, mitochondrial function, epigenetic maintenance, and inflammatory response.
View Pathway
NMN (precursor) Tryptophan (de novo) NR (precursor) CD38 consumes NAD+ (aging ↑) NAD+ Pool Sirtuins SIRT1 · SIRT2 · SIRT3 · SIRT4–7 Resveratrol SIRT1 activator DNA Repair (PARP1, SIRT6) Mitochondrial Function (SIRT3, PGC-1α) Inflammation Reduction (NF-κB suppression) Epigenetic Regulation (Histone deacetylation) Genomic Stability Cellular Energy ↑ Reduced Inflammaging Youthful Gene Expr. NAD+ declines ~50% between ages 40 and 60 Restoring NAD+ reactivates sirtuin-mediated cellular maintenance
G
GLP-1 Signaling
Glucagon-Like Peptide-1 receptor agonists — regulate insulin secretion, appetite, gastric motility, and emerging neuroprotective and cardiovascular effects.
View Pathway
Semaglutide / Tirzepatide / Retatrutide GLP-1 Ligand Binding DPP-4 degrades native GLP-1 (t½ ~2min) GLP-1 Receptor G-protein coupled (Gsα) cAMP ↑ PKA / EPAC Activation Insulin Secretion ↑ (glucose-dependent) Appetite Suppression (hypothalamic signaling) Gastric Slowing (delayed emptying) Neuroprotection (BDNF, anti-inflam.) Cardio Benefits (anti-atherosclerotic) GLP-1 agonists resist DPP-4 degradation for sustained activation Benefits extend beyond glycemic control to cardiovascular, neurological, and metabolic health
Autophagy
The cellular self-eating mechanism — damaged organelles and misfolded proteins are sequestered, delivered to lysosomes, and recycled into raw building blocks.
View Pathway
Fasting / CR Rapamycin (mTOR inhib.) Spermidine / Fisetin 1. ULK1 Complex Activation ULK1 · ATG13 · FIP200 · ATG101 2. Beclin-1 / VPS34 Complex Nucleation & PI3P generation 3. Phagophore Isolation membrane forms 4. Autophagosome Sealed vesicle LC3-II conjugation Lysosome 5. Fusion 6. Recycled Components Amino acids, lipids, nucleotides Autophagy declines with age, allowing damaged components to accumulate Restoring autophagic flux is a core strategy in longevity research
Senescence & Senolytics
Senescent cells cease dividing but resist apoptosis, secreting inflammatory factors (SASP). Senolytic compounds selectively clear these cells, reducing chronic inflammation.
View Pathway
THE PROBLEM THE SOLUTION DNA Damage Oxidative Stress Telomere Erosion Senescent Cell Growth arrest (p16/p21) + apoptosis resistance SASP IL-6, IL-8, TNF-α, MMPs, VEGF Chronic Inflammation (Inflammaging) Tissue Fibrosis (ECM degradation) Paracrine Senescence (spreads to neighbors) Senolytics Fisetin, D+Q, Navitoclax Selective Clearance Target BCL-2/BCL-xL anti-apoptotic Reduced Inflammation Tissue Rejuvenation Stem cell niche restoration Physical Function ↑ Healthspan ↑ Reduced Age- Related Disease Senescent cell burden increases exponentially after age 60 Periodic senolytic clearance may reduce the inflammatory load driving age-related disease

For Educational & Research Purposes Only. This website is an informational resource presenting published scientific research. It does not constitute medical advice, diagnosis, or treatment recommendations. All referenced studies are from independent peer-reviewed journals. Consult a licensed healthcare provider before using any compound. Annume Vitality Lab makes no claims regarding the safety, efficacy, or legal status of any compound referenced herein. Products are intended for laboratory research use. No statements on this site have been evaluated by the FDA.

Stay Informed
Research updates, new compound spotlights, and longevity science — delivered monthly.